Page 51 - 中国全科医学2022-08

·944· http://www.chinagp.net E-mail:zgqkyx@chinagp.net.cn

of resistance in castration-resistant prostate cancer （CRPC）［J］. Monit，2018，24：7541-7547. DOI：10.12659/MSM.909772.
Transl Androl Urol，2015，4（3）：365-380. DOI：10.3978/ ［37］LI Y H，BAI W J，ZHANG J J. miR-200c-5p suppresses
j.issn.2223-4683.2015.05.02. proliferation and metastasis of human hepatocellular carcinoma
［24］MARCUS A I，PETERS U，THOMAS S L，et al. Mitotic kinesin （HCC） via suppressing MAD2L1［J］. Biomed Pharmacother，
inhibitors induce mitotic arrest and cell death in Taxol-resistant 2017，92：1038-1044. DOI：10.1016/j.biopha.2017.05.092.
and-sensitive cancer cells［J］. J Biol Chem，2005，280（12）： ［38］CHOI J W，KIM Y，LEE J H，et al. High expression of spindle
11569-11577. DOI：10.1074/jbc.M413471200. assembly checkpoint proteins CDC20 and MAD2 is associated with
［25］HE H Q，HAO J，DONG X，et al. ZRSR2 overexpression is a poor prognosis in urothelial bladder cancer［J］. Virchows Arch，
frequent and early event in castration-resistant prostate cancer 2013，463（5）：681-687. DOI：10.1007/s00428-013-1473-6.
development［J］. Prostate Cancer Prostatic Dis，2021，24（3）： ［39］RAEMAEKERS T，RIBBECK K，BEAUDOUIN J，et al.
775-785. DOI：10.1038/s41391-021-00322-7. NuSAP，a novel microtubule-associated protein involved in mitotic
［26］WANG Q，LI Z A，YANG J，et al. Loss of NEIL3 activates spindle organization［J］. J Cell Biol，2003，162（6）：1017-
radiotherapy resistance in the progression of prostate cancer［J］. 1029. DOI：10.1083/jcb.200302129.
Cancer Biol Med，2021. DOI：10.20892/j.issn.2095-3941.2020.0550. ［40］GORDON C A，GONG X，GANESH D，et al. NUSAP1 promotes
［27］KIM M Y，JUNG A R，SHIN D，et al. Niclosamide exerts invasion and metastasis of prostate cancer［J］. Oncotarget，
anticancer effects through inhibition of the FOXM1-mediated DNA 2017，8（18）：29935-29950. DOI：10.18632/oncotarget.15604.
damage response in prostate cancer［J］. Am J Cancer Res， ［41］GULZAR Z G，MCKENNEY J K，BROOKS J D. Increased
2021，11（6）：2944-2959.
expression of NuSAP in recurrent prostate cancer is mediated by
［28］YU H T. Cdc20：a WD40 activator for a cell cycle degradation
E2F1［J］. Oncogene，2013，32（1）：70-77. DOI：10.1038/
machine［J］. Mol Cell，2007，27（1）：3-16. DOI：10.1016/
onc.2012.27.
j.molcel.2007.06.009.
［42］GORDON C A，GULZAR Z G，BROOKS J D. NUSAP1 expression
［29］GAYYED M F，EL-MAQSOUD N M，TAWFIEK E R，et al.
is upregulated by loss of RB1 in prostate cancer cells［J］.
A comprehensive analysis of CDC20 overexpression in common
Prostate，2015，75（5）：517-526. DOI：10.1002/pros.22938.
malignant tumors from multiple organs：its correlation with tumor
［43］WU Y G，LIU H X，GONG Y F，et al. ANKRD22 enhances breast
grade and stage［J］. Tumour Biol，2016，37（1）：749-762.
cancer cell malignancy by activating the Wnt/β-catenin pathway
DOI：10.1007/s13277-015-3808-1.
via modulating NuSAP1 expression［J］. Bosn J Basic Med Sci，
［30］WANG L X，YANG C L，CHU M，et al. Cdc20 induces
2021，21（3）：294-304. DOI：10.17305/bjbms.2020.4701.
the radioresistance of bladder cancer cells by targeting FoxO1
［44］GUO H，ZOU J P，ZHOU L，et al. NUSAP1 promotes gastric
degradation［J］. Cancer Lett，2021，500：172-181. DOI：
cancer tumorigenesis and progression by stabilizing the YAP1
10.1016/j.canlet.2020.11.052.
protein［J］. Front Oncol，2020，10：591698. DOI：10.3389/
［31］YANG G，WANG G，XIONG Y F，et al. CDC20 promotes
fonc.2020.591698.
the progression of hepatocellular carcinoma by regulating
［45］ZHANG Y Y，HUANG K T，CAI H H，et al. The role of nucleolar
epithelial-mesenchymal transition［J］. Mol Med Rep，2021，24
spindle-associated protein 1 in human ovarian cancer［J］.
（1）：483. DOI：10.3892/mmr.2021.12122.
J Cell Biochem，2020，121（11）：4397-4405. DOI：10.1002/
［32］DAI L，SONG Z X，WEI D P，et al. CDC20 and PTTG1 are
jcb.29661.
important biomarkers and potential therapeutic targets for metastatic
［46］XU Z Y，WANG Y，XIONG J，et al. NUSAP1 knockdown inhibits
prostate cancer［J］. Adv Ther，2021，38（6）：2973-2989.
cell growth and metastasis of non-small-cell lung cancer through
DOI：10.1007/s12325-021-01729-3.
regulating BTG2/PI3K/Akt signaling［J］. J Cell Physiol，2020，
［33］ZHANG Q，HUANG H，LIU A，et al. Cell division cycle 20 （CDC20）
235（4）：3886-3893. DOI：10.1002/jcp.29282.
drives prostate cancer progression via stabilization of β-catenin in
［47］GAO S，YIN H B，TONG H，et al. Nucleolar and spindle
cancer stem-like cells［J］. EBioMedicine，2019，42：397-407.
associated protein 1 （NUSAP1） promotes bladder cancer
DOI：10.1016/j.ebiom.2019.03.032.
progression through the TGF-β signaling pathway［J］. Onco
［34］LI K，MAO Y H，LU L，et al. Silencing of CDC20 suppresses
Targets Ther，2020，13：813-825. DOI：10.2147/OTT.S237127.
metastatic castration-resistant prostate cancer growth and enhances
［48］LI H，ZHANG W J，YAN M，et al. Nucleolar and spindle
chemosensitivity to docetaxel［J］. Int J Oncol，2016，49（4）：
associated protein 1 promotes metastasis of cervical carcinoma cells
1679-1685. DOI：10.3892/ijo.2016.3671.
by activating Wnt/β-catenin signaling［J］. J Exp Clin Cancer
［35］TO-HO K W，CHEUNG H W，LING M T，et al. MAD2DeltaC
induces aneuploidy and promotes anchorage-independent growth in Res，2019，38（1）：33. DOI：10.1186/s13046-019-1037-y.
human prostate epithelial cells［J］. Oncogene，2008，27（3）： ［49］LIU Z X，GUAN C Q，LU C H，et al. High NUSAP1 expression
347-357. DOI：10.1038/sj.onc.1210633. predicts poor prognosis in colon cancer［J］. Pathol Res Pract，
［36］WU Y，TAN L M，CHEN J J，et al. MAD2 combined with mitotic 2018，214（7）：968-973. DOI：10.1016/j.prp.2018.05.017.
spindle apparatus （MSA） and anticentromere antibody （ACA） （收稿日期：2021-10-11；修回日期：2021-12-20）
for diagnosis of small cell lung cancer （SCLC）［J］. Med Sci （本文编辑：贾萌萌）